Somatic inactivation of Nfl in hematopoietic cells results in a progressive myeloproliferative disorder

被引:141
作者
Le, DT
Kong, N
Zhu, Y
Lauchle, JO
Aiyigari, A
Braun, BS
Wang, E
Kogan, SC
Le Beau, MM
Parada, L
Shannon, KM
机构
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[3] Univ Texas, SW Med Ctr, Dallas, TX USA
[4] Univ Chicago, Hematol Oncol Sect, Dept Med, Chicago, IL 60637 USA
[5] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
关键词
D O I
10.1182/blood-2003-08-2650
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The NF1 tumor suppressor gene encodes a guanosine triphosphotase (GTPase)activating protein that negatively regulates Ras signaling and is inactivated in a subset of juvenile myelomonocytic leukemias (JMMLs). Adoptive transfer of fetal liver cells from Nf1 mutant mice models JMML; however, this system has important limitations as a platform for performing biologic and preclinical studies. We have exploited the interferon-inducible Mx1-Cre transgene to ablate a conditional mutant Nf1 allele in hematopoietic cells. Somatic inactivation of Nf1 induces a myeloproliferative disorder with 100% penetrance that is associated with a subacute clinical course, tissue infiltration by myeloid cells, hypersensitivity to granulocyte-macrophage colony stimulating factor, hyperproliferation, and resistance to apoptosis. These Mx1-Cre, Nf1(flox/flox) mice establish a tractable experimental model for testing therapeutics and for identifying mutations that cooperate with hyperactive Ras in myeloid leukemogenesis. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:4243 / 4250
页数:8
相关论文
共 54 条
[21]   Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia [J].
Higuchi, M ;
O'Brien, D ;
Kumaravelu, P ;
Lenny, N ;
Yeoh, EJ ;
Downing, JR .
CANCER CELL, 2002, 1 (01) :63-74
[22]   Ras redux: rethinking how and where Ras acts [J].
Hingorani, SR ;
Tuveson, DA .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (01) :6-13
[23]   Lymphoproliferative defects in mice lacking the expression of neurofibromin:: functional and biochemical consequences of Nf1 deficiency in T-cell development and function [J].
Ingram, DA ;
Zhang, L ;
McCarthy, J ;
Wenning, MJ ;
Fisher, L ;
Yang, FC ;
Clapp, DW ;
Kapur, R .
BLOOD, 2002, 100 (10) :3656-3662
[24]   Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo [J].
Ingram, DA ;
Yang, FC ;
Travers, JB ;
Wenning, MJ ;
Hiatt, K ;
New, S ;
Hood, A ;
Shannon, K ;
Williams, DA ;
Clapp, DW .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (01) :181-187
[25]   Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice [J].
Iversen, PO ;
Lewis, ID ;
Turczynowicz, S ;
Hasle, H ;
Niemeyer, C ;
Schmiegelow, K ;
Bastiras, S ;
Biondi, A ;
Hughes, TP ;
Lopez, AF .
BLOOD, 1997, 90 (12) :4910-4917
[26]   Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R [J].
Iversen, PO ;
Rodwell, RL ;
Pitcher, L ;
Taylor, KM ;
Lopez, AF .
BLOOD, 1996, 88 (07) :2634-2639
[27]   TUMOR PREDISPOSITION IN MICE HETEROZYGOUS FOR A TARGETED MUTATION IN NF1 [J].
JACKS, T ;
SHIH, TS ;
SCHMITT, EM ;
BRONSON, RT ;
BERNARDS, A ;
WEINBERG, RA .
NATURE GENETICS, 1994, 7 (03) :353-361
[28]   Comprehensive genotypic analysis of leukemia: clinical and therapeutic implications [J].
Kelly, L ;
Clark, J ;
Gilliland, DG .
CURRENT OPINION IN ONCOLOGY, 2002, 14 (01) :10-18
[29]   FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model [J].
Kelly, LM ;
Liu, Q ;
Kutok, JL ;
Williams, IR ;
Boulton, CL ;
Gilliland, DG .
BLOOD, 2002, 99 (01) :310-318
[30]   Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice [J].
Kogan, SC ;
Ward, JM ;
Anver, MR ;
Berman, JJ ;
Brayton, C ;
Cardiff, RD ;
Carter, JS ;
de Coronado, S ;
Downing, JR ;
Fredrickson, TN ;
Haines, DC ;
Harris, AW ;
Harris, NL ;
Hiai, H ;
Jaffe, ES ;
MacLennan, ICM ;
Pandolfi, PP ;
Pattengale, PK ;
Perkins, AS ;
Simpson, RM ;
Tuttle, MS ;
Wong, JF ;
Morse, HC .
BLOOD, 2002, 100 (01) :238-245